Breaking News Instant updates and real-time market news.

XPER

Xperi

$25.55

-0.15 (-0.58%)

, SSNLF

Samsung

16:32
09/28/17
09/28
16:32
09/28/17
16:32

Tessera files patent infringement suit against Samsung

Tessera Technologies and certain of its subsidiaries filed legal proceedings today against Samsung Electronics (SSNLF) and certain of its affiliates, alleging infringement of 24 patents that cover a wide range of semiconductor processing, bonding, and packaging technologies, as well as imaging technologies. Tessera is a subsidiary of Xperi (XPER). The legal proceedings were filed in the U.S. International Trade Commission, three U.S. federal district courts, and certain international jurisdictions, alleging infringement by Samsung's semiconductor products, its Galaxy S6, S7, S8, and Note 8 smartphones, and other products. "Samsung has benefitted from its use of our semiconductor technologies for 20 years, having entered into its first license with Tessera, Inc. in 1997. Samsung has also been a customer of our FotoNation imaging technologies, and has expressed interest in certain of our other solutions. Samsung's most recent semiconductor patent license expired in December 2016, but we believe it is continuing to use our patented technologies without authorization, and without paying us fair compensation," said Jon Kirchner, the Company's CEO. "We diligently tried to work through our differences with Samsung over an extended period of time, and while we remain in dialogue, unfortunately at this point the parties have not been able to come to an agreement."

XPER

Xperi

$25.55

-0.15 (-0.58%)

SSNLF

Samsung

  • 08

    Oct

  • 22

    Oct

XPER Xperi
$25.55

-0.15 (-0.58%)

07/03/17
CHLM
07/03/17
NO CHANGE
Target $48
CHLM
Buy
ITC decision should drive settlement talks for Xperi, says Craig-Hallum
Craig-Hallum analyst Richard Shannon said the ITC's ruling over a patent in the dispute between Xperi (XPER) and Broadcom (AVGO) "strongly suggests" an import restriction could eventually be implemented on a variety of Broadcom devices and he believes notice of a violation could spur settlement talks between the two. Shannon, who sees considerable upside potential for Xperi if both this patent fight and a re-licensing with Samsung are favorably resolved, reiterates his Buy rating on the stock.
SSNLF Samsung

05/17/17
MSCO
05/17/17
NO CHANGE
Target $177
MSCO
Overweight
Apple target raised to $177 at Morgan Stanley after survey shows rising loyalty
Morgan Stanley analyst Katy Huberty reported that the firm's recent survey of 1,000 U.S. consumers shows a rising iPhone retention rate, with 92% of iPhone owners who see upgrading their phone in the next 12 months saying they plan to stick to an iPhone, up from the 86% retention rate in last year's survey. Apple's (AAPL) 92% loyalty rate "dwarfs" that of all other vendors, with its biggest competitor, Samsung (SSNLF), seeing a 77% retention rate, she noted. Huberty, who sees Apple being positioned to gain increasing U.S. smartphone share, raised her price target on Apple to $177 from $161 and keeps an Overweight rating on the stock.
08/22/17
OPCO
08/22/17
NO CHANGE
Target $35
OPCO
Underperform
Synaptics price target lowered to $35 from $45 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz lowered his price target for Synaptics (SYNA) to $35 from $45, citing his bearish outlook on the company's fingerprint and DDIC business. The analyst's model implies "significant" fingerprint revenue loss from Samsung (SSNLF) and ongoing decline of DDIC revenues from Apple (AAPL). Meanwhile, Uerkwitz believes its new products such as optical fingerprint sensor and OLED DDIC are unlikely to offset the decline until after FY19. He reiterates an Underperform rating on Synaptics' shares.
09/13/17
STFL
09/13/17
NO CHANGE
STFL
Buy
Foldable smartphones another potential catalyst for Coherent, says Stifel
Stifel analyst Patrick Newton noted that AP reported yesterday that the President of Samsung's (SSNLF) mobile business said the company could release its anticipated foldable smartphone as soon as next year. Such a potential launch, and likely broader adoption of the technology by peers, is a potential long-term catalyst for Coherent (COHR) and other such equipment suppliers whose revenues are linearly correlated with total screen area, he tells investors. Also, higher resolution OLED displays, like the one confirmed yesterday for Apple's (AAPL) iPhone X, are a positive for Coherent's future recurring revenue from laser discharge units, added Newton, who keeps a Buy rating on Coherent shares.
09/14/17
KEYB
09/14/17
NO CHANGE
KEYB
Lack of Band 71 inclusion a near-term negative for T-Mobile, says KeyBanc
KeyBanc analyst Brandon Nispel says that the lack of inclusion of band 71, or 600 MHz spectrum, in iconic device launches from Samsung (SSNLF) and Apple (AAPL) is a clear negative for T-Mobile (TMUS). T-Mobile spent $8B to purchase this spectrum and will spend more capital going forward to build it out, without having the ability to put it to use for at least another year, he notes. Nispel believes investors are likely to view this as negative, and it could cause some weakness to shares.

TODAY'S FREE FLY STORIES

07:56
02/22/18
02/22
07:56
02/22/18
07:56
Conference/Events
The FTC to hold a meeting »

Open Commission Meeting…

HASI

Hannon Armstrong

$20.77

-0.22 (-1.05%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Hannon Armstrong analyst commentary  »

Hannon Armstrong weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$125.67

-0.35 (-0.28%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Workday analyst commentary  »

Workday price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

NFX

Newfield Exploration

$23.20

-2.53 (-9.83%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Upgrade
Newfield Exploration rating change  »

Newfield Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CNP

CenterPoint Energy

$26.23

-0.5 (-1.87%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Hot Stocks
CenterPoint targets FY18 Energy Services operating income $55M-$65M »

Says capital rate base…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 19

    Mar

  • 06

    Apr

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

07:53
02/22/18
02/22
07:53
02/22/18
07:53
Conference/Events
STAT Plus to hold webinar »

STAT Senior Science…

AAOI

Applied Optoelectronics

$34.55

1.22 (3.66%)

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Recommendations
Applied Optoelectronics analyst commentary  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 29

    Mar

07:51
02/22/18
02/22
07:51
02/22/18
07:51
General news
Futures pointing to higher open »

Stock futures have…

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Conference/Events
The FCC to hold a commission meeting »

Open Commission Meeting…

07:50
02/22/18
02/22
07:50
02/22/18
07:50
Conference/Events
Federal Reserve Bank of New York President speaks at press briefing »

New York Federal Reserve…

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

07:49
02/22/18
02/22
07:49
02/22/18
07:49
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

LNKD

Acquired by MSFT

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Conference/Events
Detroit Economic Club to hold a breakfast meeting »

Brenda Meller, Owner and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MCS

Marcus

$26.10

1 (3.98%)

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Earnings
Marcus reports Q4 EPS $1.21, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    May

PHX

Panhandle Oil & Gas

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Initiation
Panhandle Oil & Gas initiated  »

Panhandle Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

CRM

Salesforce

$114.48

0.13 (0.11%)

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

07:46
02/22/18
02/22
07:46
02/22/18
07:46
Conference/Events
FDA to co-host a workshop »

The FDA, American…

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.